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Abstract
The tumor suppressor Rb is thought to control cell proliferation, survival and differentiation. We recently showed that
differentiating Rb-deficient mouse myoblasts can fuse to form short myotubes that quickly collapse through a mechanism
involving autophagy, and that autophagy inhibitors or hypoxia could rescue the defect leading to long, twitching
myotubes. Here we determined the contribution of pRb relatives, p107 and p130, to this process. We show that chronic or
acute inactivation of Rb plus p107 or p130 increased myoblast cell death and reduced myotube formation relative to Rb loss
alone. Treatment with autophagy antagonists or hypoxia extended survival of double-knockout myotubes, which appeared
indistinguishable from control fibers. In contrast, triple mutations in Rb, p107 and p130, led to substantial increase in
myoblast death and to elongated bi-nuclear myocytes, which seem to derive from nuclear duplication, as opposed to cell
fusion. Under hypoxia, some rare, abnormally thin triple knockout myotubes survived and twitched. Thus, mutation of p107
or p130 reduces survival of Rb-deficient myoblasts during differentiation but does not preclude myoblast fusion or
necessitate myotube degeneration, whereas combined inactivation of the entire Rb family produces a distinct phenotype,
with drastically impaired myoblast fusion and survival.
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Introduction
The retinoblastoma tumor suppressor (Rb) plays crucial roles in
development and homeostasis, and is commonly inactivated in
human malignancies [1,2,3]. Rb is a member of a family of
proteins including p107 and p130 that exhibit similar or opposing
functions in different tissues [4]. The Rb family is thought to
control cell proliferation and survival by binding E2F family of
transcription factors and repressing transcription by recruiting
chromatin-modifying factors such as HDAC1 [5]. The Rb family
may also regulate differentiation by controlling expression of
differentiation factors such as PPARc and PGC-1a and by
sequestering inhibitors of differentiation including ID2, HDAC1,
EID1 and RBP2 [6,7,8,9,10,11]. Rb in particular was shown to
potentiate the activity of lineage-specific transcription factors such
as the myogenic factors MyoD and myogenin during skeletal
myogenesis [12,13,14,15,16,17]. These myogenic proteins bind
promoters of muscle-specific genes like muscle creatine kinase
(MCK) to activate the muscle differentiation program
[18,19,20,21]. Indeed, ectopic expression of MyoD in Rb-deficient
fibroblasts fails to induce myogenesis [22,23].
In keeping with Rb’s ability to potentiate myogenic conversion
in fibroblasts, pRb is required for proper skeletal myogenesis in
vivo. Rb-null embryos die at embryonic day (E) 13.5–14.5,
exhibiting ectopic proliferation, massive apoptosis and incomplete
differentiation in a number of tissues where Rb is normally highly
expressed [24,25,26,27,28,29,30]. The early embryonic death
precluded studies of terminal skeletal myogenesis, which occurs
after embryonic day (E) 14.5. An Rb mini-gene (mgRb), expressed
exclusively in the placenta and the nervous system, but not in
skeletal muscles, was used to extend the life-span of Rb
2/2
embryos to birth [31,32](Z. Jiang and EZ, unpublished). In
mgRb:Rb
2/2 embryos, myotubes are initially formed at E14.5–
15.5, but thereafter degenerate in a process accompanied by
massive myoblast apoptosis, endoreduplication within myotubes
and normal expression of early myogenic differentiation markers
(MHC, cardiac actin) but not late markers (MCK, MRF4). Similar
muscle defects were subsequently reported after Rb-null embryos
were partially rescued by other means [8,33,34]. Moreover, a
muscle-specific ablation of a floxed Rb allele (Rb
f) via Myf5-Cre
demonstrated impaired muscle differentiation both in vitro and in
vivo [35]. Finally, analysis of Rb mutant myoblasts (in vitro) revealed
a similar pattern observed in Rb mutant fetuses (in vivo); that is,
myoblasts initially fuse to form short myotubes but quickly
degenerate and never twitch [36].
Although these observations implicate pRb in terminal
myogenesis, a direct assignment of differentiation function to
pRb was hampered by the fact that terminal differentiation is
intimately coupled to myoblast survival. To overcome this
obstacle, the ability of Rb mutant myoblasts to differentiate has
been assessed in the presence of survival factors. Remarkably,
expression of Bcl-2 rescued the Rb defect leading to long myotubes
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ating Rb-deficient myotubes exhibited perinuclear mitochondrial
aggregation and autophagy, not apoptosis, and inhibition of
autophagy or exposure to hypoxia suppressed myotube degener-
ation [36]. Although differentiating Rb mutant myotubes initially
failed to exit the cell cycle, the rescued myotubes eventually
became stably post-mitotic despite absence of Rb. Together these
results suggest that Rb is required to coordinate cell cycle exit with
survival during the onset of differentiation, but not for actively
stimulating the differentiation program.
An important unresolved question is whether p107 and p130
compensate or exacerbate the differentiation defect of Rb-
deficient myoblasts. In particular, we wish to know whether the
initial cell fusion and myotube formation that occurs in the
absence of pRb is p107 and/or p130-dependent. There are
several notable differences among Rb family members, including
their affinity to E2F members and other factors [5,37], effects
on cell cycle exit and senescence [38,39], and roles during
embryogenesis and cancer [24,40,41,42,43,44,45,46,47]. During
myogenesis, over-expression of p107 suppressed ectopic cell
proliferation in Rb
2/2 myotubes [16], whereas over-expression
of p130, but not pRb, inhibited myogenic differentiation in Rb
proficient mouse C2 myoblasts [48]. These findings raised the
possibility that p107 might act in a manner redundant to Rb,
whereas p130 might promote defects resulting from Rb deficiency
during myogenic differentiation.
To address the function of the Rb protein family during
terminal differentiation, we analyzed double Rb
2/2:p107
2/2 and
Rb
2/2:p130
2/2 as well as triple Rb
2/2:p107
2/2:p130
2/2
mutant myoblasts following chronic or acute inactivation of Rb.
We report that loss of either p107 or p130 enhanced the survival
defect of Rb-deficient myoblasts, implying that both of these Rb-
related proteins partially compensate for Rb loss. Nevertheless,
myoblasts lacking Rb plus either p107 or p130 could differentiate
and twitch, as long as autophagic cell death is suppressed or
metabolism is shifted to glycolysis under hypoxia. In contrast,
myoblasts lacking all three Rb family members do not efficiently
fuse or survive, indicating that expression of at least one Rb family
protein is essential for these processes.
Results
Combined mutation in p130 does not counteract Rb
myogenic defects in mgRb:Rb
2/2:p130
2/2 double
mutant fetuses
As noted, over-expression of p107 suppresses ectopic cell
proliferation in Rb
2/2 myotubes [16], whereas over-expression of
p130 inhibits myogenic differentiation in Rb proficient mouse C2
myoblasts[48],suggestingthatcombinedlossofRbplusp107orRb
plus p130 might worsen or ameliorate the Rb myogenic defect,
respectively. To test the effects of p107 and p130 on differentiation
of Rb-deficient myoblasts, we generated and intercrossed
mgRb:Rb
+/2:p107
+/2 and mgRb:Rb
+/2:p130
+/2 double hetero-
zygote mice. Consistent with previous studies on early death of Rb/
p107 double mutant embryos [42,49], we were unable recover live
E14.5–E16.5 mgRb:Rb
2/2:p107
2/2 double mutant embryos after
breeding mgRb:Rb
+/2:p107
+/2 mice (not shown). In contrast,
E14.5–E16.5 mgRb:Rb
2/2:p130
2/2 fetuses were identified fol-
lowing mgRb:Rb
+/2:p130
+/2 interbreeding at the expected
Mendelian frequency (6/53=11.32%; expected 12.5%; Table 1).
At E17.5, the frequency of mgRb:Rb
2/2:p130
2/2 double
knockout (KO) embryos dropped to 1/59 (1.69%), whereas viable
Rb
2/2singleknockoutswerepresentat9/59(24%),approximating
the expected 25% frequency.
Compared to E16.5 mgRb:Rb
2/2 single KO embryos,
mgRb:Rb
2/2:p130
2/2 double knockout (DKO) fetuses displayed
a more pronounced hunchback, suggesting reduced muscle toning
(Fig. 1A, top panels). However, histological sections through
epaxial and hypaxial skeletal muscles of mgRb:Rb
2/2:p130
2/2
fetuses revealed similar defects as in mgRb:Rb
2/2 littermates,
including reduced density and shortened myofibers, and enlarged
nuclei within myotubes compared to control (Fig. 1A, arrow-
heads). Expression of myosin heavy chain (MHC), an early marker
of differentiation, was similar in wild type and mutant embryos
whereas expression of troponin T, a late marker of differentiation,
was similarly reduced in single and double mutants relative to
control (Fig. 1B). Terminal deoxynucleotidyl transferase biotin-
dUTP nick end labeling (TUNEL, [50]) analysis revealed no
obvious differences in apoptosis: 22.269.3% and 20.164.7% for
single and DKO, respectively (not shown). Thus, despite the
enhanced hunchback mgRb:Rb
2/2:p130
2/2 DKO embryos, we
did not detect obvious changes in myoblast differentiation in vivo.
Combined mutations in Rb and p130 accelerated
myotube degeneration in vitro
To test for a cell-autonomous effect of combined mutations in
Rb and p130, we derived primary myoblasts from E16.5
mgRb:Rb
2/2:p130
2/2 limb muscles. Absence of pRb and p130
was verified in mgRb:Rb
2/2:p130
2/2 cultures 2 days post-
differentiation (DM-2) (Fig. 1C). We note that the p130
2/2 lane
lacked full-length p130, but contained a lower band, which could
represent a cross reactive protein or a truncated/spliced p130
variant. Expression of p107, which was undetected in DM-2
control myotube cultures, was elevated in Rb KO myotubes and
further increased in Rb/p130 DKO cultures (Fig. 1C). This
observation is consistent with the presence of E2F binding sites in
the p107 promoter and its regulation by pRb [51,52], and may
partly compensate for the combined loss of pRb and p130 in these
DKO cells.
Under differentiation conditions, wild-type myoblasts fused to
form long multinucleated myotubes that twitched for weeks in
culture (Fig. 1D). In contrast, both mgRb:Rb
2/2 and
mgRb:Rb
2/2:p130
2/2 myoblasts initially fused to form short
myotubes containing 3–6 nuclei, but underwent rapid degenera-
tion beginning 2–3 days post-differentiation; by day 5–6 virtually
all myotubes had degenerated. Reproducibly, the mgRb:Rb
2/2:
p130
2/2 DKO myoblasts exhibited reduced myotube formation
relative to mgRb:Rb
2/2 cultures, but similar degeneration
kinetics (Fig. 1D).
Table 1. Frequency of mgRb:Rb
2/2:p130
2/2 embryos
recovered.
Gestation mgRb:Rb
2/2 * mgRb:Rb
2/2:p130
2/2 * mgRb:Rb
2/2:p130
2/2 **
E14.5 4/54 (7.41%) 6/54 (11.11%) Not determined
E15.5 8/41 (19.51%) 6/41 (14.63%) 6/38 (15.79%)
E16.5 11/53 (20.75%) 6/53 (11.32%) 2/20 (10.0%)
E17.5 9/59 (24.09%) 1/59 (1.69%) 4/45 (8.89%)
*Mutant embryos obtained from mgRb:Rb
+/2:p130
+/2 6mgRb:Rb
+/2:p130
2/2
intercrosses. Total of 5 in utero deaths at E17.5 were not included. A frequency
of 12.5% is expected in each indicated group.
**Mutant embryos obtained from mgRb:Rb
+/2:p130
2/2 6mgRb:Rb
+/2:p130
2/2
intercrosses. Total of 4 in utero deaths at E17.5 were not included. A frequency
of 25% is expected in mgRb:Rb
2/2:p130
2/2 group.
doi:10.1371/journal.pone.0017682.t001
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(Fig. 2A, top), nuclei in Rb-deficient myotubes incorporate BrdU
when stimulated with mitogens, indicating a failure in establishing
a permanent cell cycle exit (Fig. 2A, middle) [16,23,36]. To test
the cell cycle status of DKO myotubes, cultures were differentiated
for 1 day and then re-stimulated with growth medium in the
presence of BrdU. Like Rb
2/2, the mgRb:Rb
2/2:p130
2/2
myotubes incorporated BrdU (Fig. 2A, bottom). We next tested
whether mgRb:Rb
2/2:p130
2/2 myotube degeneration was
associated with apoptosis. TUNEL-positive nuclei were detected
in unfused myoblasts, but not within myotubes, and were more
abundant in Rb and Rb/p130 DKO cultures than in control
(Fig. 2B). Importantly, the level of apoptosis was slightly, but
reproducibly, elevated in Rb/p130 DKO relative to Rb KO
cultures (Fig. 2B, see below).
To determine whether combined mutations in Rb and p130 led
to further disruption of the mitochondrial network seen in Rb
deficient myotubes [36], we used MitoTrackerH, a live-cell probe
that accumulates in mitochondria with intact membrane potential.
In DM-2 control myotubes, MitoTrackerH staining revealed a
uniform, net-like organization of mitochondria throughout the
cytoplasm (Fig. 2C, top). However, both mgRb:Rb
2/2 and
Figure 1. Analysis of myogenesis mgRb:Rb
2/2:p130
2/2 double mutant embryos. (A) Appearance of ctrl, mgRb:Rb
2/2 and mgRb:Rb
2/2:
p130
2/2 embryos at E16.5 (a–c). Hematoxylin & eosin (H&E) histology staining reveals the cellular morphology at mid-sagittal section (d–f), epaxial
muscles (g–i) and hypaxial muscles (j–l). Arrowheads point to enlarged nuclei within myofibers. (B) Confocal images showing fast troponin T (green)
expression in skeletal muscle sections of control (ctrl) (a–b) mgRb:Rb
2/2 (c–d) and mgRb:Rb
2/2:p130
2/2 (e–f) embryos. MHC (green) expression in
skeletal muscle sections of ctrl (g) mgRb:Rb
2/2 (h) and mgRb:Rb
2/2:p130
2/2 (i) embryos. DAPI was used to counter-stain nuclei (blue). (C) Top,
western blot analysis for pRb and p107 in DM-2 ctrl, mgRb:Rb
2/2 and mgRb:Rb
2/2:p130
2/2 myoblast cultures. Tubulin was used as loading control.
Bottom, western blot analysis of p130 in DM-2 ctrl and mgRb:Rb
2/2:p130
2/2 cultures. Arrow indicates location of p130. Lower band represents a
splice variant or cross-reactive protein. (D) Average number of myotubes counted on indicated days post-differentiation. Each time point represents
an average 6 s.d. of 6 fields at 200X (n=4).
doi:10.1371/journal.pone.0017682.g001
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2/2:p130
2/2 myotubes exhibited relatively sparse
cytosolic staining and strong perinuclear MitoTrackerH-positive
clusters in ,70% of myotubes, indicative of autophagy (Fig. 2C).
Importantly, there was no detectable difference in the level of
perinuclear aggregation in single and DKO myoblasts. Together,
these results indicate that loss of p130 does not ameliorate the Rb
myogenic defect, but rather, exacerbates it by reducing myoblast
survival prior to fusion.
Efficient rescue of Rb/p130 DKO myoblast degeneration
by Bcl-2, autophagy inhibitor and hypoxia
We next asked whether inhibition of autophagy would rescue
muscle degeneration in mgRb:Rb
2/2:p130
2/2 DKO cultures as
it does for Rb-deficient myotubes [36]. Remarkably, adenovirus
mediated transduction of Bcl-2, which inhibits both apoptosis and
autophagy [53], effectively rescued myogenic degeneration of
mgRb:Rb
2/2:p130
2/2 DKO myotubes, leading to long twitching
myotubes (Fig. 3A). This striking result demonstrates that when
provided with a survival signal that counteracts the pro-apoptotic
effect of Rb loss, myotube formation and maintenance does not
require active participation of pRb and p130. We previously
demonstrated that inhibition of autophagy by 3-methyladenine (3-
MA), an antagonist of a class III phosphatidylinositol 3-kinase,
Vps34, which is necessary for autophagic vesicle nucleation [54],
also rescued the degeneration of Rb-deficient myotubes [36]. A
single dose of 3-MA administered just prior to induction of
differentiation prevented degeneration of mgRb:Rb
2/2:p130
2/2
DKO myotubes (Fig. 3B). The 3-MA-rescued myotubes twitched
for weeks in culture and were indistinguishable from control
myotubes (Videos S1 and S2). The pan-PPAR agonist bezafi-
brate [55,56], which induces mitochondrial biogenesis, also
rescued the collapse of mgRb:Rb
2/2:p130
2/2 DKO myotubes
with similar efficiency as 3-MA (Fig. 3B). As control, ectopic
expression of a constitutively active, phospho-mutant pRb
(Ad.Rb
DK11) [57] prevented degeneration of mgRb:Rb
2/2:
p130
2/2 DKO myotubes (Fig. 3A, bottom panel).
In addition to autophagy antagonists, hypoxia (,1% O2)
rescued the myogenic defect induced by loss of Rb by redirecting
metabolism from oxidative phosphorylation to glycolysis [36]. To
test whether hypoxia could also rescue the myogenic defect in
Rb/p130 DKO myoblasts, mgRb:Rb
2/2:p130
2/2 and control
cultures were induced to differentiate under hypoxia. Remarkably,
despite the enhanced cell death and reduced myotube formation
in mgRb:Rb
2/2:p130
2/2 cultures relative to mgRb:Rb
2/2,
hypoxia efficiently maintained the survival of DKO myotubes,
leading to long, twitching myotubes (Fig. 3C). These results
indicate that combined loss of Rb plus p130 reduces myoblast
survival and myotube formation relative to Rb loss alone. Yet,
when cell death is inhibited, DKO myotubes can differentiate as
efficiently as Rb mutant or control cultures, demonstrating that
neither factor is required for stimulating or maintaining the
differentiation program.
Inactivation of Rb but not p107 plus p130 leads to
ectopic DNA synthesis and degeneration of primary
myotubes
To characterize the functions of p107 and p130 during skeletal
myogenesis in combination with Rb deletion, we isolated primary
myoblasts from E16.5 Rb
f/f:p107
2/2:p130
2/2 composite mutant
embryos. In these mice, Rb exon 19 is flanked by loxP sites,
allowing acute inactivation through Cre mediated excision [58].
Transduction of Rb
f/f myoblasts with Ad.Cre at a high multiplicity
of infection (1300) led to loss of pRb expression in all cells as
determined by immunostaining and immunoblotting (Fig. 4A–B),
and to myotube degeneration (Fig. 4C). Deletion of p107 and
p130 was detected by PCR (not shown) and confirmed by
immunoblotting (Fig. 4D).
We first tested whether combined mutations in p107 and p130
resulted in deregulated cell proliferation in response to a
differentiation signal. Interestingly, RNAi inhibition of Rb family
members in C2C12 myotubes suggests that knock-down of p107
plus p130 does not cause cell cycle re-entry [59]. This could be due
Figure2.DifferentiationofmgRb:Rb
2/2:p130
2/2 DKO myoblasts. (A) Confocal microscopy analysis for BrdU incorporation in ctrl, mgRb:Rb
2/2
and mgRb:Rb
2/2:p130
2/2 myotubes at DM-2. Myoblasts were differentiated for 1 day, then exposed to 20 mM BrdU for an additional 16 hr in the
presence of growth medium (GM) and immuno-stained for MHC (red) and BrdU (green). Arrowheads label BrdU positive nuclei within myotubes. (B)
MHC (red) and TUNEL (green) staining at DM-2. Arrowheads indicate TUNEL positive nuclei, which are invariably located outside myotubes. (C)
MitotrackerH (red) staining at DM-2. Arrowheads point to large MitotrackerH-positive perinuclear aggregates.
doi:10.1371/journal.pone.0017682.g002
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addition, C2C12 cells lack Arf [60], and therefore the observed
effect could be confounded by deregulation of the ARF/MDM2/
p53 pathway. To address the consequences of complete KO of
p107 plus p130 in cells with an intact ARF-p53 pathway, we
induced primary Rb
f/f:p107
2/2:p130
2/2 and control myoblasts
to differentiate and then re-stimulated with growth medium in the
presence of BrdU. Rb
Df mutant myotubes incorporated BrdU
(Fig. 4E, G). In contrast, Rb
f/f:p107
2/2:p130
2/2 double KO
myotubes (which retain the two Rb
f/f alleles) did not (Fig. 4F, G).
Thus, Rb loss prevents cell cycle exit during terminal differenti-
ation and this function is unique to Rb. Notably, although Rb
f/f:
p107
2/2:p130
2/2 double mutant myotubes survived and
twitched like control Rb-proficient cultures, we consistently
observed reduced myotube formation in p107/p130 DKO
cultures relative to control (e.g. Fig. 5B).
Acute inactivation of Rb plus p107 or p130 leads to
reduced myotube formation whereas TKO myoblasts
form short bi-nuclear myocytes
To investigate the effect of Rb plus p107 and/or p130 on
myogenesis, proliferating Rb
f/f,R b
f/f:p130
2/2,R b
f/f:p107
2/2
and Rb
f/f:p130
2/2:p107
2/2 myoblasts were transduced with
Ad.cre or control empty vector (Ad.EV) and induced to
differentiate 48 hr later (permitting pre-existing pRb protein
degradation). Both Rb
Df:p130
2/2 and Rb
Df:p107
2/2 myoblasts
differentiated to form short myotubes by DM-2 with slightly less
myotubes in the Rb/p107 than the Rb/p130 DKO cultures
(Fig. 5A). In addition to multinucleated myotubes, Rb
Df:p107
2/2,
and to a lesser extent Rb
Df:p130
2/2 and Rb
Df myoblasts formed
elongated MHC-positive myocytes containing a single nucleus.
Quantification of multinucleated myotubes relative to total
MHC-positive cells (i.e. myocytes plus myotubes) revealed that
Rb
Df,R b
Df:p107
2/2 and Rb
Df:p130
2/2 cultures contained 51%,
31% and 43% myotubes relative to total MHC-positive cells,
respectively (Fig. 5B). Rb
Df:p130
2/2:p107
2/2 TKO myoblasts
formed primarily elongated myocytes that typically contained one
or two nuclei (Fig. 5A,h ;Fig. 6A, bottom right); some rare
myotubes containing three nuclei were also observed (Fig. S1).
The percentage of short bi-nuclear myotubes relative to total
MHC-positive cells in the TKO cultures (single-nucleus myocytes
plus binuclear myocytes or myotubes) was ,9% (Fig. 5B).
Reduced myotube formation in DKO and TKO cultures
correlates with increased apoptosis in differentiating
myoblasts
The reduced number of myotubes in Rb/p107, Rb/p130 and
Rb/p107/p130 mutant cultures relative to Rb KO and control
cultures could be due to intrinsic defects in differentiation or to
excessive myoblast cell death, which would diminish the available
pool of competent neighboring myocytes for fusion. To distinguish
between these possibilities, we first assessed the level of
mitochondrial perinuclear aggregation in differentiating myotubes.
Following acute inactivation of Rb, transiently formed Rb
Df
myotubes, like mgRb:Rb
2/2 myotubes, exhibited abnormal
perinuclear aggregation of mitochondria (Fig. 6A, bottom left
Figure 3. Rescue of mgRb:Rb
2/2:p130
2/2 myogenic defect by
autophagy inhibitors and hypoxia. (A) Brightfield images of
mgRb:Rb
2/2:p130
2/2 myoblasts transduced with Ad.GFP, Ad.Bcl-2 or
Ad.RbDK11 and then induced to differentiate for 14 days. Arrowheads
point to myotubes. (B) Average number of mgRb:Rb
2/2:p130
2/2
myotubes following treatment with 3-MA, bezafibrate or DM as
indicated. Counts are average 6 s.d. of 6 fields at 200X (n=3). (C)
Immunostaining for MHC (green) in ctrl and mgRb:Rb
2/2:p130
2/2
cultures differentiated under normoxia or hypoxia. Note myotubes in
mgRb:Rb
2/2:p130
2/2 cultures at DM-5 under hypoxia but not
normoxia. Nuclei were counterstained with DAPI.
doi:10.1371/journal.pone.0017682.g003
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Df versus p107
2/2:p130
2/2 myotubes. (A) Rb
f/f myoblasts were transduced with Ad.GFP or Ad.cre
and 48 hr later were immunostained for pRb (red). Nuclei were counterstained with DAPI. (B) Rb
f/f myoblasts were transduced with Ad.EV or Ad.cre
and immunoblotted for pRb 48 hr later. Tubulin served as loading control. (C) Rb
f/f myoblasts were transduced with Ad.cre, induced to differentiate
for 2 or 6 days and immunostained for MHC (red). (D) Western blot analysis of pRb, p107 and p130 in skeletal muscle of E16.5 Rb
f/f:p107
+/2:
p130
+/2 (ctrl) and Rb
f/f:p107
2/2:p130
2/2 fetuses. (E) Immunostaining for BrdU and MHC in Ad.EV and Ad.cre transduced Rb
f/f myoblasts at DM-2.
Myoblasts were differentiated for 1 day, then exposed to 20 mM BrdU for an additional 16 hr in the presence of GM and stained for MHC (red) and
BrdU (green). Arrowheads label BrdU positive nuclei within myotubes. (F) Immunostaining for BrdU and MHC in Rb
f/f,R b
f/f:p107
2/2,R b
f/f:p130
2/2 and
Rb
f/f:p107
2/2:p130
2/2 myoblasts at DM-2. Myoblasts were differentiated for 1 day, then exposed to 20 mM BrdU for an additional 16 hr in the
presence of GM and stained for MHC (red) and BrdU (green). Note absence of BrdU-positive nuclei in myotubes. (G) Quantification of BrdU
incorporation in Ad.EV or Ad.cre transduced Rb
f/f and Rb
f/f:p107
2/2:p130
2/2 myotubes at DM-2.
doi:10.1371/journal.pone.0017682.g004
Figure5.Differentiationpotentialofdouble andtripleKOmyoblasts.(A) ImmunostainingforMHC(green)inAd.EVand Ad.cre transducedRb
f/f,
Rb
f/f:p107
2/2,R b
f/f:p130
2/2 and Rb
f/f:p107
2/2:p130
2/2 myoblast cultures at DM-2. Nuclei were counterstained with DAPI. (B) Quantification of percent
multinucleated myotubes relative to total number of MHC-positive cells (myocytes plus myotubes) in Ad.EV and Ad.cre transduced Rb
f/f,R b
f/f:
p107
2/2,R b
f/f:p130
2/2 and Rb
f/f:p107
2/2:p130
2/2 myoblasts at DM-2 under normoxia. Numbers within bars indicate % for the respective samples.
doi:10.1371/journal.pone.0017682.g005
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p107 and Rb/p130 DKO myotubes was similar to that observed
in Rb KO cultures. In contrast, the short bi-nuclear TKO
myocytes did not exhibit mitochondrial aggregation in the
perinuclear region (Fig. 6A, bottom right panel).
TUNEL analysis revealed that differentiating TKO myoblasts
underwent the highest level of apoptosis (119%) relative to the level
of apoptosis in wild-type, followed by Rb/p107 (49%), Rb/p130
(24%)andRb(19%)KOmyoblasts(Fig. 6B–C). Thus,thereduced
myotube formation (and increase in elongated myocytes) was
directly proportional to the level of apoptosis in the various mutant
cultures. Interestingly, it was reported that myoblasts seeded at low-
density do not fuse under differentiation conditions but instead form
elongated myocytes that undergo differentiation in the absence of
fusion [60]. Thus, reduced myotube formation in the DKO and
TKO cultures likely reflect, at least in part, the increased apoptosis
and reduced number of competent myocytes available for fusion.
Hypoxia efficiently rescues myotubes formed in the
absence of Rb and p130 or p107, but not in the absence
of all three Rb family proteins
Hypoxia most effectively rescues the myogenic defect following
acute inactivation of Rb [36]. To test whether hypoxia could
prevent myotube degeneration following acute inactivation of Rb
plus its relatives, Rb
f/f,R b
f/f:p130
2/2,R b
f/f:p107
2/2 and Rb
f/f:
p130
2/2:p107
2/2 myoblasts were transduced with Ad.cre or
Ad.EV and then either maintained under normoxia or shifted to
hypoxic conditions. Under normoxia, no myotubes survived by
DM-5 (Fig. 5A). However, under hypoxia, Rb
Df:p130
2/2 and
Rb
Df:p107
2/2 myotubes survived and twitched, and appeared
indistinguishable from Rb
Df or control myotubes (Fig. 7A–B;
videos S3–5). In striking contrast, elongated TKO myocytes/
myotubes degenerated, forming ultra-thin myocytes/myotubes,
very few of which nonetheless twitched (video S6). The ratio of
myotubes to myocytes at DM-5 was similar, relative to DM-2
(compare Fig. 5B to Fig. 7C). To directly test this, we induced
the various cultures to differentiate under hypoxia and then
counted the number of myotubes at DM-2 and DM-6. As shown
in Figure 7D, the ratio of myotubes at DM-2 and DM-6 was
similar in the two DKO cultures indicating that once formed,
myotubes can survive in hypoxia independently of pRb-p107 or
pRb-p130 protein family. In contrast, very few TKO binuclear
myocytes/myotubes survived at DM-6 under hypoxia, and they
were ultra-thin and clearly abnormal (Fig. 8A). Thus, at least one
pRb protein family is required for robust differentiation even
under hypoxic conditions, which rescue Rb-deficient myotube
degeneration.
Figure 6. Increased apoptosis associated with differentiation of double and triple KO myoblasts. (A) MitotrackerH staining of Ad.EV and
Ad.cre transduced Rb
f/f,R b
f/f:p107
2/2,R b
f/f:p130
2/2 and Rb
f/f:p107
2/2:p130
2/2 myoblasts at DM-2. Arrowheads point to large perinuclear
aggregates in Ad.cre transduced myotubes. (B) TUNEL staining (green) of Ad.EV and Ad.cre transduced Rb
f/f (a–b), Rb
f/f:p107
2/2 (c–d), Rb
f/f:p130
2/2
(e–f) and Rb
f/f:p107
2/2:p130
2/2 (g–h) cultures at DM-2. Nuclei were counterstained with DAPI. Note that TUNEL positive nuclei are outside myotubes.
(C) Percent increase in TUNEL-positive cells in Ad.cre relative to Ad.EV transduced cultures. Error bars represent s.d. *-p,0.05 and **-p,0.07 t-test
comparisons relative to Rb
f/f.
doi:10.1371/journal.pone.0017682.g006
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PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17682Figure 7. Differentiation of double and triple KO myoblasts under hypoxia. (A) Immunostaining for MHC (green) of Ad.EV (a,c,e,g) or Ad.cre
(b,d,f,h) transduced Rb
f/f,R b
f/f:p107
2/2,R b
f/f:p130
2/2 and Rb
f/f:p107
2/2:p130
2/2 cultures at DM-5 in hypoxia. Inlets, DAPI staining for nuclei. (B)
Quantification of myotube formation in Rb
f/f,R b
f/f:p107
2/2,R b
f/f:p130
2/2 and Rb
f/f:p107
2/2:p130
2/2 cultures transduced with Ad.EV or Ad.cre and
induced to differentiate 48 hr later for 5 days. Counts represent the average number of myotubes at DM-5 of 6 representative fields (n=4); error bars
represent s.d. *-p,0.05 and **-p,0.07. (C) Quantification of percent multinucleated myotubes relative to total number of MHC-positive cells in Ad.EV
or Ad.cre transduced Rb
f/f,R b
f/f:p107
2/2,R b
f/f:p130
2/2 and Rb
f/f:p107
2/2:p130
2/2 cultures at DM-5 under hypoxia. Numbers within bars indicate %
for respective samples. (D) Quantification of myotube formation in Rb
f/f,R b
f/f:p107
2/2,R b
f/f:p130
2/2 and Rb
f/f:p107
2/2:p130
2/2 cultures transduced
with Ad.EV or Ad.cre and induced to differentiate in hypoxia. Counts were conducted at DM-2 and DM-6. Error bars represent s.d.
doi:10.1371/journal.pone.0017682.g007
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PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e17682Figure 8. Evidence that bi-nuclear TKO myotubes originate from nuclear duplication, not cell fusion. (A) Bright-field images of Ad.EV
and Ad.cre transduced Rb
f/f:p107
2/2:p130
2/2 cultures at DM-6 in hypoxia. Arrowheads point to myotubes. Note the presence of a thin myotube in
Ad.cre transduced culture. (B) Top row, low magnification image of Ad.EV or Ad.cre transduced Rb
f/f:p107
2/2:p130
2/2 cultures immunostained for
pRb (green) at DM-2 (400x). Bottom row, high magnification (630x) of Ad.EV or Ad.cre transduced Rb
f/f:p107
2/2:p130
2/2 cultures induced to
Rb Family in Skeletal Myogenesis
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acytokinetic mitosis and not fusion
If the bi-nuclear TKO myocytes originate from cell fusion, this
would suggest that the entire Rb family is dispensable for this
process. To address this possibility, we first asked whether the bi-
nuclear TKO myocytes represented rare Rb
f/f:p130
2/2:p107
2/2
myoblasts in which the Rb
f/f allele had not been deleted.
However, upon staining, none of over 80 short binuclear myocytes
expressed pRb (n=2) (Fig. 8B). Next, we asked whether the
elongated binuclear myocytes originated from cell fusion of TKO
myocytes or from acytokinetic mitosis (i.e. absence of cytokinesis at
the end of mitosis), which occurs normally in cardiac myocytes and
other tissues [61]. To distinguish between these possibilities,
proliferating TKO or control myoblasts (two independent cultures
for each) were labeled with BrdU for 24 hr. The labeled cells were
then mixed with an equal number of unlabeled TKO or control
myoblasts, respectively, and induced to differentiate. Control
cultures contained three populations of myotubes (BrdU
+/BrdU
+;
BrdU
+/BrdU
2; BrdU
2/BrdU
2), with an average of 35% (of
.200 myotubes) containing a mixture of BrdU
+ and BrdU
2
nuclei, indicative of cell fusion (n=4) (Fig. 8C). In striking
contrast, with the exception of one elongated bi-nuclear TKO
myocyte with BrdU
+/BrdU
2 nuclei, more than 150 other bi-
nuclear TKO myocytes contained either BrdU
2/BrdU
2 or
BrdU
+/BrdU
+ nuclei, strongly suggesting that binuclear TKO
myocytes originate primarily from acytokinetic mitosis, not from
cell fusion. This is consistent with our observation that bi-nuclear
TKO myocytes do not exhibit perinuclear aggregation of
mitochondria as observed in Rb KO and DKO myotubes
(Fig. 6A). Thus, these results suggest that efficient myocyte fusion
requires the presence of at least one member of the Rb protein
family.
Discussion
We report that mutant myoblasts lacking Rb and one of its
relatives, p107 or p130, can undergo robust myogenic differen-
tiation under conditions we previously established whereby the
survival defect in Rb-deficient myotubes is rescued by autophagy
antagonists or hypoxia. In contrast, under the same conditions,
combined mutations in all Rb protein family members, pRb, p107
and p130, severely abrogate myogenic differentiation. Thus,
myoblast fusion and myotube survival require at least one Rb
family member. We discuss our findings in the context of recent
published work by another group demonstrating that various
tissue-types can differentiate in the absence of Rb family and
propose a tissue specific active/default model for Rb during cell
fate determination and differentiation.
It is commonly thought that the tumor suppressor pRb plays at
least two independent functions during differentiation: control of
cell division and apoptosis through inhibition of E2F responding
genes, and stimulation of the differentiation program through
activation of differentiation factors. However, we recently showed
that survival factors, autophagy inhibitors and hypoxia can
prevent the degeneration of Rb-deficient muscles, leading to
contracting myotubes [36]. While these observations challenge the
notion that pRb is actively required to stimulate the differentiation
program, the possibility that p107 and/or p130 partially
compensate for pRb during differentiation was not ruled out.
Specifically, p107 or p130 could account for the ability of Rb-
deficient myoblasts to fuse to form short myotubes prior to
degeneration. In addition, it was unresolved whether p130
compensates or counteracts pRb during differentiation [48]. Here,
we addressed these issues by analyzing primary myoblasts with
composite mutations in the Rb gene family. We showed that
combined mutations in pRb plus p107 or pRb plus p130 increased
apoptosis in myoblasts, and accordingly, reduced the number of
DKO myotubes. p107 was clearly more critical than p130 in
preventing apoptosis of Rb-deficient myoblasts during differenti-
ation. Nevertheless, the myotubes that formed in the absence of
Rb and either p107 or p130 survived and twitched under hypoxia
or following treatment with autophagy-antagonists.
Several studies suggest that the Rb family may affect
differentiation and lineage commitment by transcriptionally
regulating the expression of differentiation factors such as PPARc
and PGC-1a, by sequestering inhibitors of differentiation like ID2,
HDAC, EID1 and RBP2 [6,7,8,9,10,11], or by binding and
stimulating differentiation factors such as CBFA1 during osteoblast
differentiation, C/EBPb during adipocyte differentiation and
MyoD and myogenin during myogenesis [12,13,14,15,16,17]. A
recent genome-wide mammalian protein-protein interaction
analysis independently demonstrated that human RB1 and p130
but not p107 interact with MYOD1, RUNX2 and C/EBP [62].
p107 does not seem to interact with MyoD or any other
differentiation factor, which is consistent with its reduced
expression during differentiation. Thus, the ability of Rb/p130
DKO myoblasts to fully differentiate when treated with autophagy
inhibitors or hypoxia is remarkable and questions the notion that
the Rb family is actively required for differentiation. Possibly,
interaction of pRb and p130 with MyoD may be required for cell
survival or cell cycle exit, but it does not seem essential for
differentiation per se.
While we observed a quantitative reduction in myotube
formation between single KO and double KO myoblasts, there
was a qualitative difference between DKO and TKO cultures.
TKO myoblast cultures exhibited excessive myoblast death and
primarily formed elongated, bi-nuclear myocytes and some rare
bona fide myotubes. Using nuclear labeling and mixing experi-
ments, we present evidence suggesting that the bi-nuclear
myocytes originate from acytokinetic mitosis, not cell fusion.
Under hypoxia, the short TKO myocytes/myotubes became
abnormally thin, yet some rare myocytes/myotubes persisted and
twitched. The appearance of rare twitching TKO myotubes with
three nuclei suggests that some cell fusion can occur, albeit
inefficiently, in the absence of all three Rb protein family. We
conclude that the presence of a single member of the Rb protein
family is required for efficient myocyte fusion, survival and
differentiation even under hypoxia. However, we cannot rule out
the possibility that under certain conditions, yet to be identified,
TKO myoblasts might fuse to form normal-like twitching
myotubes.
After submission of this manuscript, the Sage group reported
that Rb-family TKO embryos form various tissues containing
multiple cell lineages. However, skeletal myotubes were completely
differentiate and then immunostained for pRb (green), demonstrating absence of detectable pRb within binuclear myocyte. Nuclei were
counterstained with DAPI. Arrowheads point to nuclei in the myocyte. (C) Immunostaining for MHC (red) and BrdU (green) at DM-2 of Ad.EV and
Ad.cre transduced Rb
f/f:p107
2/2:p130
2/2 cultures, which were induced differentiate after equal mixing of BrdU
+ labeled and BrdU
2 myoblast
populations. Note mixed BrdU
+ and BrdU
2 nuclei in control myotube (top panel) but only BrdU
2:BrdU
2 or BrdU
+:BrdU
+ nuclei in TKO myotubes
(middle and bottom, respectively).
doi:10.1371/journal.pone.0017682.g008
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embryos [63]. Although more detailed analyses of the TKO
muscle defect is needed, these observations are consistent with our
in vitro results demonstrating an autonomous requirement for the
Rb family for myogenesis, even under hypoxia.
We propose the following active/default model for pRb. In this
model, pRb is actively required for differentiation of certain
tissues, whereas other tissues, including adipose and those that
develop early in embryogenesis before Rb family gene expression
is observed [24], can differentiate in the absence of Rb, i.e. as a
default pathway. Indeed, it was recently shown that Rb status
dictates fate choice between osteogenic and adipogenic differen-
tiation by positively regulating the osteogenic factor RUNX2 and
negatively regulating the adipogenic factor PPARc [6]. Likewise,
Rb (and p107) is required for differentiation of adipocytes to white
adipose tissue by suppressing PGC-1a expression, whereas the
default differentiation in the absence of Rb or p107 is brown fat
[46]. In TKO hematopoietic stem cells, myeloid progenitors
hyper-proliferate whereas lymphoid progenitors are ablated [64].
While Rb may be required solely for survival of muscle, bone,
white fat and lymphoid cells, these studies suggest that it is actively
engaged in sequestering inhibitors of differentiation or stimulating
expression or activity of differentiation factors in stem/progenitors
cells at the stage of bifurcation into different cell lineages. Whether
Rb dictates cell fate choice during differentiation of multipotent
stem cells in the somite or in Pax3
+/Pax7
+ muscle stem cells in the
dermomyotome [65] is yet to be determined. Such instructive
functions by the Rb family during cell fate determination may no
longer be required once a cell becomes committed to a specific
lineage, and the major function of Rb in committed cells might be
to allow proper cell cycle exit and survival; a function that can be
bypassed by survival factors or hypoxia. The diminished ability of
TKO myoblasts to differentiate and survive may be a consequence
of complete deregulation of the E2F protein family, which may
create conditions that are incompatible with differentiation, or
reflect a requirement for Rb protein family in myoblast fusion and
myotube survival, which cannot be rescued by hypoxia.
Finally, Rb but not p107 or p130 is often lost in cancer. As a
potential basis for this observation, it was suggested that Rb
inactivation is uniquely required for cancer progression because
only after its loss can tumor cells escape senescence under
oncogenic stress [39]. Conversely, in response to p16
ink4a over-
expression, mutations in p107 plus p130 allow cells to escape cell
cycle inhibition as efficiently as mutations in Rb [38], suggesting
that these factors have similar functions in cell cycle exit in
response to CDK4/6 inhibition. Here, using KO myoblasts, we
demonstrated that Rb, but not p107 plus p130, is uniquely
required for cell cycle exit during terminal differentiation of
primary myoblasts. Thus, the exclusive role of Rb but not its
relatives in certain cancers may be due to its unique role in
enforcing cell cycle exit during terminal differentiation. Likely,
disruption of either function of pRb, senescence or cell cycle exit
during differentiation, can lead to neoplastic transformation
depending on the cellular and oncogenic context.
Methods
Mouse maintenance, genotyping & timed-pregnancy
Experiments were performed in accordance with guidelines of
the Canadian Council on Animal Care and approved by the
TGRI-UHN Animal Care Committee, Ontario (Approval ID:
AUP1050). Mice were genotyped using DNA extracted from tail
biopsies and the following primers: mgRb:Rblox – forward 59-
ATTTCAGAAGGTCTGCCAAC, reverse 59-AGAGCAGGC-
CAAAAGCCAGGA; Rb mutant, AATTGCGGCCGCATCTG-
CATCTTTATCGC and GAAGAACGAGATCAGCAG; Rb
wild-type AATTGCGGCCGCATCTGCATCTTTATCGC and
CCCATGTTCGGTCCCTAG; Rb
floxed (Rb18 + Rb19E) GG-
CGTGTGCCATCAATG and CTCAAGAGCTCAGACTCA-
TGG; p130 wild-type ACGGATGTCAGTGTCACG and TA-
CATGGTTTCCTTCAGCGG; p130 mutant ACGGATGT-
CAGTGTCACG and GAAGAACGAGATCAGCAG; p107
wild-type TCGTGAGCGGATAGAAAG and GTGTCCAGCA-
GAAGTTA; p107 mutant TCGTGAGCGGATAGAAAG and
CCGCTTCCATTGCTCAGCGG. For timed-pregnancies, mice
were mated overnight and the day of vaginal plug observation was
considered E0.5.
Isolation of myoblasts and cell culture
Skeletal muscles from limbs E16.5–E17.5 embryos obtained
following timed-pregnancy were used to generate primary
myoblast cultures. More than 700 embryos were used in this
study. To maintain consistency between experiments, primary
myoblasts were induced to differentiate at passage two. Muscle
tissues were digested for 20 min at 37uCi n8 0 ml solution
containing 1.5 U/ml collagenase IV (Sigma), 2.4 U/ml Dispase
(Roche) and 5 mM CaCl2, gently triturated and plated onto
60 mm collagen-I coated culture dishes. Primary myoblasts were
maintained in Growth Medium (GM) - HAM’s-F10 (Lonza)
supplemented with 20% FBS (PAA) and 2.5 ng/ml basic fibroblast
growth factor (bFgf) (Sigma) - in a humidified incubator at 5%
CO2 and 37uC. To induce differentiation, myoblasts were washed
once in 1x Phosphate Buffered Saline (PBS) and shifted to
Differentiation Medium (DM) - Dulbecco’s modified Eagle’s
medium (DMEM, high-glucose and sodium pyruvate) (Sigma)
supplemented with 3% Horse Serum (PAA) [66]. For drug
treatment, a single dose of 3-methyladenine (5 mM) was added
upon differentiation. Bezafibrate (500 mM) was refreshed every
other day.
BrdU DNA synthesis assay
Post-differentiation day 1 myotube cultures were re-stimulated
in GM supplemented with 20 mM BrdU for 16 h before fixation
with 3.7% formaldehyde (10 min). For BrdU-labeled cell mixing
experiments, cultures were divided into two equal populations and
transduced with Ad.cre or Ad.EV (see Ad.cre transduction
methods). One of the two populations was fed 20 mM for 36 hr.
BrdU was then removed, both populations trypsinized, mixed in
equal proportions and plated in GM. Differentiation was induced
12–16 hr later. Cultures were permeabilized using 0.3% Triton X-
100 for 10 min, treated with 2N HCl for 25 min, and neutralized
with two washes of 0.5 M sodium borate, pH 8.5 for 5 min. After
blocking in 1.0% BSA for 20 min, primary anti-MHC antibody;
1:50 (clone MY-32, Sigma) for 1 hr, cells were washed 3x, 3 min
each with PBS. Secondary antibody: fluorescein-conjugated (Alexa
Fluor 563 (Red) - Invitrogen). BrdU was detected using anti-BrdU
antibody directly conjugated to FITC as per manufacturer’s
protocol (BD Biosciences). Images were captured using an
Axioskop2 fluorescent microscope (Carl Zeiss Inc.).
Immunofluorescence
500,000 primary myoblasts were seeded on 22 mm round
Collagen-I coated coverslips (BD Biosciences) and induced to
differentiate. Cells were fixed in 3.7% formaldehyde, permeabi-
lized in 0.3% Triton X-100 and blocked for 20 min in 1% BSA/
PBS at room temperature. Primary antibodies: MHC, 1:50 (clone
MY-32, Sigma), pRb, 1:100 (BD Biosciences), were incubated on
samples for 1 hr at room temperature. Secondary antibodies,
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Invitrogen) were added for 45 min. Nuclei were counterstained
with DAPI (Invitrogen) for 10 min and mounted in fluorescent
mounting media (Dako). Confocal images of 0.5 mm sections were
captured at room temperature using a 40x or 63x c-apochromat
objective lens (water)/1.2NA using a Zeiss LSM510 META
confocal microscope (Carl Zeiss Inc.) and Zeiss AIM 3.2
acquisition software. Adobe Photoshop CS2 was used to overlay
images.
Western Blot Analysis
Cells were lysed on ice in K4IP buffer (50 mM HEPES, pH 7.5,
0.1% Tween-20, 1 mM EDTA, 2.5 mM EGTA, 150 mM NaCl,
1.0 mM DTT, 10% Glycerol) containing protease inhibitors
(Sigma). Antibodies were used for 3 hr at room temperature or
overnight at 4uC: a/b-tubulin, 1:4000 (Cell Signaling), pRb,
1:1000 (BD Biosciences), p130 (Santa Cruz), p107 (Santa Cruz).
Secondary antibodies were HRP-linked anti-IgG, 1:2000 (Cell
Signaling) for 1.5 hr in blocking buffer and HRP activity was
detected using SuperSignal West Dura chemiluminescent sub-
strate (Pierce) and captured by X-ray film. Films were digitized
using a Canon scanner.
MitoTrackerH Red CMXRos and TUNEL Assays
Mitochondria membrane potential was detected using Mito-
TrackerH Red CMXRos according to manufacturer’s protocol
(Molecular Probes). TUNEL analysis on section was performed as
described [66]. For TUNEL analysis of tissue culture, differenti-
ating myoblasts on collagen-I coated coverslips were fixed in 3.7%
formaldehyde for 10 min, washed three times in PBS, permeabi-
lized with 0.3% Triton X-100 solution and washed 3x in PBS.
Subsequently, 30U Terminal Deoxynucleotidyl Transferase (TdT)
(Fermentas) was added to 50 ml TUNEL-Label Solution (Roche).
Nuclei were counterstained with DAPI (Invitrogen) for 10 min and
mounted in fluorescent mounting media (Dako).
Adenovirus-cre Transductions
Adenoviruses were amplified in 293T cells maintained in
DMEM plus 10% FBS and Penicillin/Streptomycin (Sigma). For
Adenovirus-cre (Ad.cre; Vector Biolabs) infection, Rb
f/f primary
myoblasts were infected with multiplicity of infection (MOI) of
1300, which completely eliminated Rb expression. At lower MOI
(,1000), some pRb positive nuclei within myoblasts were
detected. For transductions, 50,000 cells (96-well) or 450,000 cells
(22 mm round coverslip) were seeded and 8 hr later transduced
with Ad.cre or Ad.EV in 50 ml or 600 ml GM, respectively. After
18 hr, medium was re-freshed for additional 24 hr. Cells were
rinsed once using 1x PBS and switched to DM. The following
adenovirus vectors were kindly provided by Marco Crescenzi -
Ad.Bcl-2 - Dept. of Environment and Primary Prevention, Higher
Institute of Health, Viale Regina Elena 299, 00161 Roma, Italy;
Ad.EV - Genzyme Corporation, 31 New York Ave, P.O. Box
9322, Framingham, MA 01701-9322; David S. Park – Ad.Rb
DK11
and Ad.p27 - Department of Cellular and Molecular Medicine,
University of Ottawa, Ottawa, Ontario, Canada K1H 8M5.
Histology and Immunofluorescence on embryo sections
Briefly, embryos were fixed in 4% paraformaldehyde at 4uC
overnight, dehydrated, and embedded in paraffin. Sections (8 mm)
were cut using a Reichert Ultracut E microtome. For histology,
sections were stained with hematoxylin and eosin. For immuno-
fluorescence staining, samples were de-paraffinized, hydrated and
subjected to antigen retrieval by boiling in 10 mmol/L sodium
citrate (pH 6.0) for 10 min in microwave followed by 30 min
gradual cooling at room temperature. Slides were incubated with
primary troponin T, 1:200 (clone c-18, Santa Cruz) antibody or
MHC, 1:50 (clone MY-32, Sigma) in a humidified chamber at 4uC
overnight. Secondary antibody, fluorescein-conjugated (Alexa
Fluor 488 - Invitrogen) was added for 1 hr. Nuclei were
counterstained with DAPI (Invitrogen) for 10 min and mounted
in fluorescent mounting media (Dako). Images were captured
using an Axioskop2 fluorescent microscope (Carl Zeiss Inc.).
Confocal images of 0.5 mm sections were captured at room
temperature using a 40x or 63x c-apochromat objective lens
(water)/1.2NA using a Zeiss LSM510 META confocal microscope
(Carl Zeiss Inc.) and Zeiss AIM 3.2 acquisition software. Adobe
Photoshop CS2 was used to overlay images.
Brightfield Images and Videos
Brightfield images and videos were captured at room temper-
ature using 20x or 40x air-objective lenses on a Nikon TE200
microscope (Nikon) fitted with a Hamamatsu CCD digital camera.
Images were acquired using SimplePCI imaging software
(Hamamatsu). Adobe Photoshop CS2 was used to enhance clarity
and contrast using same parameters for control and experimental
samples.
Supporting Information
Figure S1 A rare TKO myotube containing 3 nuclei.
Immunostaining for pRb (green) of Ad.EV and Ad.cre transduced
Rb
f/f:p107
2/2:p130
2/2 cultures at DM-2. Top row, low
exposure images demonstrating absence of detectable pRb in
Ad.cre transduced culture. Bottom row, high exposure images to
highlight a short myotube containing 3 nuclei, which is devoid of
detectable nuclear pRb, in Ad.cre transduced Rb
f/f:p107
2/2:
p130
2/2 culture. Nuclei counterstained with DAPI.
(TIF)
Video S1 Twitching wild-type myotubes treated with 3-
MA. Control wild-type myoblasts were induced to differentiate
and treated with 3-MA and video captured at DM-5.
(SWF)
Video S2 Twitching mgRb:Rb
2/2:p130
2/2 myotubes
treated with 3-MA. mgRb:Rb
2/2:p130
2/2 myoblasts were
induced to differentiate and treated with 3-MA and video captured
at DM-5.
(SWF)
Video S3 Twitching Ad.cre transduced Rb
Df myotubes
under hypoxia. Rb
f/f myoblasts were transduced with Ad.cre,
induced to differentiate after 48 hr, transferred to hypoxia and
video captured at DM-5.
(SWF)
Video S4 Twitching Ad.cre transduced Rb
Df:p107
2/2
myotubes under hypoxia. Rb
f/f:p107
2/2 myoblasts were
transduced with Ad.cre, induced to differentiate after 48 hr,
transferred to hypoxia and video captured at DM-5.
(SWF)
Video S5 Twitching Ad.cre transduced Rb
Df:p1302/2
myotubes under hypoxia. Rb
f/f:p130
2/2 myoblasts were
transduced with Ad.cre, induced to differentiate after 48 hr,
transferred to hypoxia and video captured at DM-5.
(SWF)
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Df:p107
2/2:
p130
2/2 myotube/myocyte under hypoxia. Rb
f/f:p107
2/2:
p130
2/2 myoblasts were transduced with Ad.cre, induced to
differentiate after 48 hr, transferred to hypoxia and video captured
at DM-5.
(SWF)
Acknowledgments
We thank Zhe Jiang for advice, HuQin Li for TUNEL analysis on
histological sections, Michael Ohh for access to hypoxia incubator, Marco
Crescenzi, Karen A. Vincent and David S. Park for valuable adenovirus
vectors.
Author Contributions
Conceived and designed the experiments: GC ATH EZ. Performed the
experiments: GC ATH. Analyzed the data: GC ATH EZ. Contributed
reagents/materials/analysis tools: DC EZ. Wrote the paper: GC EZ.
References
1. Burkhart DL, Sage J (2008) Cellular mechanisms of tumour suppression by the
retinoblastoma gene. Nat Rev Cancer 8: 671–682.
2. Bremner R, Zacksenhaus E (2010) Cyclins, Cdks, E2f, Skp2, and more at the
first international RB Tumor Suppressor Meeting. Cancer Res 70: 6114–6118.
3. Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, et al. (2010) Rb deletion in
mouse mammary progenitors induces luminal-B or basal-like/EMT tumor
subtypes depending on p53 status. J Clin Invest 120: 3296–3309.
4. Cobrinik D (2005) Pocket proteins and cell cycle control. Oncogene 24:
2796–2809.
5. Chen HZ, Tsai SY, Leone G (2009) Emerging roles of E2Fs in cancer: an exit
from cell cycle control. Nat Rev Cancer 9: 785–797.
6. Calo E, Quintero-Estades JA, Danielian PS, Nedelcu S, Berman SD, et al.
(2010) Rb regulates fate choice and lineage commitment in vivo. Nature 466:
1110–1114.
7. Scime A, Soleimani VD, Bentzinger CF, Gillespie MA, Le Grand F, et al. (2010)
Oxidative status of muscle is determined by p107 regulation of PGC-1{alpha}.
J Cell Biol 190: 651–662.
8. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A (2000) Id2 is a
retinoblastoma protein target and mediates signalling by Myc oncoproteins.
Nature 407: 592–598.
9. Puri PL, Iezzi S, Stiegler P, Chen TT, Schiltz RL, et al. (2001) Class I histone
deacetylases sequentially interact with MyoD and pRb during skeletal
myogenesis. Mol Cell 8: 885–897.
10. MacLellan WR, Xiao G, Abdellatif M, Schneider MD (2000) A novel Rb- and
p300-binding protein inhibits transactivation by MyoD. Mol Cell Biol 20:
8903–8915.
11. Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WG, Jr. (2005)
Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol
Cell 18: 623–635.
12. Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, et al. (2001) The
retinoblastoma protein acts as a transcriptional coactivator required for
osteogenic differentiation. Mol Cell 8: 303–316.
13. Chen PL, Riley DJ, Chen-Kiang S, Lee WH (1996) Retinoblastoma protein
directly interacts with and activates the transcription factor NF-IL6. Proc Natl
Acad Sci U S A 93: 465–469.
14. Skapek SX, Pan YR, Lee EY (2006) Regulation of cell lineage specification by
the retinoblastoma tumor suppressor. Oncogene 25: 5268–5276.
15. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, et al. (1993)
Interaction of myogenic factors and the retinoblastoma protein mediates muscle
cell commitment and differentiation. Cell 72: 309–324.
16. Schneider JW, Gu W, Zhu L, Mahdvavi V, Nadal-Ginard B (1994) Reversal of
terminal differentiation mediated by p107 in RB-/- muscle cells. Science 264:
1467–1471.
17. Novitch BG, Spicer DB, Kim PS, Cheung WL, Lassar AB (1999) pRb is
required for MEF2-dependent gene expression as well as cell-cycle arrest during
skeletal muscle differentiation. Curr Biol 9: 449–459.
18. Buckingham M (1992) Making muscle in mammals. Trends Genet 8: 144–148.
19. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, et al. (1993)
MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:
1351–1359.
20. Olson EN, Klein WH (1994) bHLH factors in muscle development: dead lines
and commitments, what to leave in and what to leave out. Genes Dev 8: 1–8.
21. Black BL, Olson EN (1998) Transcriptional control of muscle development by
myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14:
167–196.
22. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, et al. (1998) Stable
binding to E2F is not required for the retinoblastoma protein to activate
transcription, promote differentiation, and suppress tumor cell growth. Genes
Dev 12: 95–106.
23. Chen TT, Wang JY (2000) Establishment of irreversible growth arrest in
myogenic differentiation requires the RB LXCXE-binding function. Mol Cell
Biol 20: 5571–5580.
24. Jiang Z, Zacksenhaus E, Gallie BL, Phillips RA (1997) The retinoblastoma gene
family is differentially expressed during embryogenesis. Oncogene 14:
1789–1797.
25. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, et al. (1992) Effects of
an Rb mutation in the mouse. Nature 359: 295–300.
26. Lee EYHP, Chang CY, Hu N, Wang YCJ, Lai CC, et al. (1992) Mice deficient
for Rb are nonviable and show defects in neurogenesis and haematopoiesis.
Nature 359: 288–294.
27. Clarke AR, Maandag ER, Van Roon M, Van der Lugt NMT, Van der Valk M,
et al. (1992) Requirement for a functional Rb-1 gene in murine development.
Nature 359: 328–330.
28. Lee EY-HP, Hu N, Yuan S-SF, Cox LA, Bradley A, et al. (1994) Dual roles of
the retinoblastoma protein in cell cycle regulation and neuron differentiation.
Genes & Dev 8: 2008–2021.
29. Mulligan G, Jacks T (1998) The retinoblastoma gene family: cousins
withoverlapping interests. Trends Genet 14: 223–229.
30. Macleod K (1999) pRb and E2f-1 in mouse development and tumorigenesis.
Current Opinion In Genetics & Development 9: 31–39.
31. Jiang Z, Gou Z, Saad F, Ellis J, Zacksenhaus E (2001) Retinoblastoma gene
promoter directs transgene expression exclusively to the nervous system. J Biol
Chem 276: 593–600.
32. Zacksenhaus E, Jiang Z, Chung D, Marth J, Phillips RA, et al. (1996) pRb
controls cell proliferation, differentiation and death of skeletal muscle cells and
other lineages during embryogenesis. Genes & Dev 10: 3051–3064.
33. Takahashi C, Bronson RT, Socolovsky M, Contreras B, Lee KY, et al. (2003)
Rb and N-ras function together to control differentiation in the mouse. Mol Cell
Biol 23: 5256–5268.
34. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboli A, et al. (2003) Extra-
embryonic function of Rb is essential for embryonic development and viability.
Nature 421: 942–947.
35. Huh MS, Parker MH, Scime A, Parks R, Rudnicki MA (2004) Rb is required for
progression through myogenic differentiation but not maintenance of terminal
differentiation. J Cell Biol 166: 865–876.
36. Ciavarra G, Zacksenhaus E (2010) Rescue of myogenic defects in Rb-deficient
cells by inhibition of autophagy or by hypoxia-induced glycolytic shift. J Cell
Biol, in press.
37. Castano E, Kleyner Y, Dynlacht BD (1998) Dual cyclin-binding domains are
required for p107 to function as a kinase inhibitor. Mol Cell Biol 18: 5380–5391.
38. Bruce JL, Hurford RK, Jr., Classon M, Koh J, Dyson N (2000) Requirements for
cell cycle arrest by p16INK4a. Mol Cell 6: 737–742.
39. Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, et al. (2010) Dissecting
the unique role of the retinoblastoma tumor suppressor during cellular
senescence. Cancer Cell 17: 376–387.
40. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, et al. (1996) Shared
role of the pRb-related p130 and p107 proteins in limb development. Genes &
Dev 10: 1633–1644.
41. Classon M, Dyson N (2001) p107 and p130: versatile proteins with interesting
pockets. Exp Cell Res 264: 135–147.
42. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, et al. (1996)
Targeted disruption of p107: functional overlap between p107 and Rb. Genes &
Dev 10: 1621–1632.
43. LeCouter JE, Kablar B, Whyte PF, Ying C, Rudnicki MA (1998) Strain-
dependent embryonic lethality in mice lacking the retinoblastoma-related p130
gene. Development 125: 4669–4679.
44. LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, et al. (1998) Strain-
dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in
mice lacking the Rb-related p107 gene. Mol Cell Biol 18: 7455–7465.
45. Classon M, Kennedy BK, Mulloy R, Harlow E (2000) Opposing roles of pRB
and p107 in adipocyte differentiation. Proc Natl Acad Sci U S A 97:
10826–10831.
46. Scime A, Grenier G, Huh MS, Gillespie MA, Bevilacqua L, et al. (2005) Rb and
p107 regulate preadipocyte differentiation into white versus brown fat through
repression of PGC-1alpha. Cell Metab 2: 283–295.
47. Xu XL, Fang Y, Lee TC, Forrest D, Gregory-Evans C, et al. (2009)
Retinoblastoma has properties of a cone precursor tumor and depends upon
cone-specific MDM2 signaling. Cell 137: 1018–1031.
48. Carnac G, Fajas L, L’Honore A, Sardet C, Lamb NJ, et al. (2000) The
retinoblastoma-like protein p130 is involved in the determination of reserve cells
in differentiating myoblasts. Curr Biol 10: 543–546.
49. Berman SD, West JC, Danielian PS, Caron AM, Stone JR, et al. (2009)
Mutation of p107 exacerbates the consequences of Rb loss in embryonic tissues
Rb Family in Skeletal Myogenesis
PLoS ONE | www.plosone.org 13 March 2011 | Volume 6 | Issue 3 | e17682and causes cardiac and blood vessel defects. Proc Natl Acad Sci U S A 106:
14932–14936.
50. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell
death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:
493–501.
51. Zhu L, Zhu L, Xie E, Chang LS (1995) Differential roles of two tandem E2F
sites in repression of the human p107 promoter by retinoblastoma and p107
proteins. Mol Cell Biol 15: 3552–3562.
52. Burkhart DL, Wirt SE, Zmoos AF, Kareta MS, Sage J (2010) Tandem E2F
binding sites in the promoter of the p107 cell cycle regulator control p107
expression and its cellular functions. PLoS Genet 6: e1001003.
53. Pattingre S, Levine B (2006) Bcl-2 inhibition of autophagy: a new route to
cancer? Cancer Res 66: 2885–2888.
54. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132:
27–42.
55. Wenz T, Diaz F, Spiegelman BM, Moraes CT (2008) Activation of the PPAR/
PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a
mitochondrial myopathy phenotype. Cell Metab 8: 249–256.
56. Bastin J, Aubey F, Rotig A, Munnich A, Djouadi F (2008) Activation of
peroxisome proliferator-activated receptor pathway stimulates the mitochondrial
respiratory chain and can correct deficiencies in patients’ cells lacking its
components. J Clin Endocrinol Metab 93: 1433–1441.
57. Jiang Z, Zacksenhaus E (2002) Activation of retinoblastoma protein in
mammary gland leads to ductal growth suppression, precocious differentiation,
and adenocarcinoma. J Cell Biol 156: 185–198.
58. Vooijs M, te Riele H, van der Valk M, Berns A (2002) Tumor formation in mice
with somatic inactivation of the retinoblastoma gene in interphotoreceptor
retinol binding protein-expressing cells. Oncogene 21: 4635–4645.
59. Blais A, van Oevelen CJ, Margueron R, Acosta-Alvear D, Dynlacht BD (2007)
Retinoblastoma tumor suppressor protein-dependent methylation of histone H3
lysine 27 is associated with irreversible cell cycle exit. J Cell Biol 179: 1399–1412.
60. Pajcini KV, Corbel SY, Sage J, Pomerantz JH, Blau HM (2010) Transient
inactivation of Rb and ARF yields regenerative cells from postmitotic
mammalian muscle. Cell Stem Cell 7: 198–213.
61. Ullah Z, Lee CY, Depamphilis ML (2009) Cip/Kip cyclin-dependent protein
kinase inhibitors and the road to polyploidy. Cell Div 4: 10.
62. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, et al. (2010) An
atlas of combinatorial transcriptional regulation in mouse and man. Cell 140:
744–752.
63. Wirt SE, Adler AS, Gebala V, Weimann JM, Schaffer BE, et al. (2010) G1 arrest
and differentiation can occur independently of Rb family function. J Cell Biol
191: 809–825.
64. Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S,
McLaughlin ME, et al. (2008) Hematopoietic stem cell quiescence is maintained
by compound contributions of the retinoblastoma gene family. Cell Stem Cell 3:
416–428.
65. Buckingham M, Vincent SD (2009) Distinct and dynamic myogenic populations
in the vertebrate embryo. Curr Opin Genet Dev 19: 444–453.
66. Ho A, Li H, Hakem R, Mak TW, Zacksenhaus E (2004) Coupling of Caspase-9
to Apaf-1 in response to loss of pRb or cytotoxic drugs is cell type dependent.
EMBO J 23: 460–472.
Rb Family in Skeletal Myogenesis
PLoS ONE | www.plosone.org 14 March 2011 | Volume 6 | Issue 3 | e17682